Tegoprazan as a diagnostic test for acid reflux
Treatments studied
Part of Digestive system clinical trials.
This study tests whether a medication called tegoprazan can help doctors diagnose acid reflux (GERD). Eligible participants will take the medication and track their symptoms to see if it improves them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 75 years old.
- You have had heartburn or acid regurgitation at least twice a week for at least 3 months.
- You have not used certain stomach-acid medications (like proton pump inhibitors) in the past 2 weeks, or other acid reducers in the past week.
- You do not have serious gastrointestinal conditions like bleeding, narrowing, or a history of stomach surgery.
- You do not have significant liver or kidney problems.
- You are not taking certain medications continuously, such as steroids, NSAIDs, blood thinners, or certain psychiatric drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well and how safely the drug tegoprazan works for people with gastroesophageal reflux disease (GERD). It may help if you have symptoms like heartburn or acid reflux.
This study tests whether a newer medicine, tegoprazan, works better than an older one, pantoprazole, for treating heartburn and acid reflux. Both are stomach acid reducers. You may be able to join if you have been diagnosed with GERD and your symptoms have lasted for at least three months.
This trial tests a medicine called vonoprazan for people whose acid reflux symptoms (like heartburn or coughing) don't get better with usual treatment. It aims to see if vonoprazan can help control those symptoms.
This trial tests whether a stomach-acid-reducing drug (tegoprazan) helps prevent complications during planned surgeries under general anesthesia. It is for adults aged 20–69 with a non-emergency surgery and a BMI under 35.
This trial tests a new medicine called anaprazole for people with moderate to severe reflux esophagitis (chronic heartburn and damage to the food pipe). It compares anaprazole to a standard treatment to see which works better and is safer.
This study tests a stomach-protecting medicine called tegoprazan for people who have had a stroke and are starting antiplatelet therapy. It aims to prevent stomach complications like ulcers or bleeding.
Hear when a new GERD (Gastroesophageal Reflux Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.